Pharma’s Ghost Labs Find New Life
Pharma’s Ghost Labs Find New Life
Finding new tenants for former drug development sites isn’t always easy. But a new, thriving industry has materialized to do just that.
Pharma’s Ghost Labs Find New Life
Pharma’s Ghost Labs Find New Life

Finding new tenants for former drug development sites isn’t always easy. But a new, thriving industry has materialized to do just that.

Finding new tenants for former drug development sites isn’t always easy. But a new, thriving industry has materialized to do just that.

Glaxosmithkline
GlaxoSmithKline to Acquire Cancer Biotech TESARO for $5.1 Billion
GlaxoSmithKline to Acquire Cancer Biotech TESARO for $5.1 Billion
Carolyn Wilke | Dec 3, 2018
The purchase aims to build GSK’s oncology pipeline.
Novartis and Sanofi Stockpile Meds in Preparation for Brexit
Novartis and Sanofi Stockpile Meds in Preparation for Brexit
Ashley Yeager | Aug 3, 2018
If the UK leaves the EU in March without a deal, transport of insulin and other essential drugs could be delayed.
Layoffs, Restructuring at GSK
Layoffs, Restructuring at GSK
Tracy Vence | Dec 4, 2014
GlaxoSmithKline is eliminating 900 US jobs—most in R&D.
Uncloaking Clinical Trials
Uncloaking Clinical Trials
Beth Marie Mole | Oct 16, 2012
Glaxo­SmithKline will share long-sought, raw trial data—but access will be tightly controlled.